PCOS (Polycystic Ovary Syndrome)

PCOS is the most common endocrine disorder affecting women of reproductive age, with prevalence estimates ranging from 8 to 13% globally. It is characterized by some combination of irregular or absent ovulation, elevated androgens (testosterone and related hormones), and polycystic ovarian morphology on ultrasound. PCOS is a clinical pattern, not a single disease; presentations vary widely between people.

For cycle syncing, PCOS is the single most important edge case to address, because the practice assumes a regular ovulatory cycle that many PCOS users do not have.

This is informational, not medical advice. PCOS diagnosis and treatment require evaluation by a qualified provider.

How PCOS is diagnosed

The most widely used framework is the Rotterdam criteria (2003): diagnosis requires at least 2 of 3 features.

  1. Oligo-ovulation or anovulation. Cycles longer than 35 days, fewer than 8 cycles per year, or completely absent periods.
  2. Clinical or biochemical hyperandrogenism. Either visible signs (acne, hirsutism, male-pattern hair loss) or elevated androgen levels on blood test.
  3. Polycystic ovarian morphology on ultrasound. Typically 12 or more follicles per ovary (2 to 9mm in size), or increased ovarian volume.

The "cysts" in PCOS are misleadingly named. They are not true cysts but immature follicles that did not develop fully. Each ovary may have many of them.

Other conditions can mimic PCOS (thyroid disorders, hyperprolactinemia, late-onset congenital adrenal hyperplasia, Cushing's syndrome). A thorough workup rules these out before confirming PCOS.

Common symptoms

  • Irregular or absent periods. Often 35 to 90+ days apart, sometimes with no periods for months.
  • Difficulty getting pregnant. Due to irregular ovulation.
  • Acne. Particularly along the jawline and chin; often persists past adolescence.
  • Hirsutism. Excess hair growth in male-pattern areas (face, chest, back, abdomen).
  • Male-pattern hair loss. Thinning at the crown.
  • Weight gain, particularly central. Increased visceral fat.
  • Insulin resistance. Present in roughly 70% of PCOS cases. Often the upstream driver of androgen excess.
  • Skin tags and dark patches (acanthosis nigricans), often in the neck, armpits, or groin.

Not every person with PCOS has every symptom. Lean PCOS exists; severe acne PCOS exists; predominantly metabolic PCOS exists. The label covers a wide phenotypic range.

The underlying biology

The dominant model centers on a feedback loop between insulin resistance, androgens, and ovulation:

  1. Insulin resistance raises blood insulin levels.
  2. High insulin stimulates ovarian androgen production.
  3. Elevated androgens disrupt normal follicle maturation.
  4. Follicles stall in early development and accumulate (the "polycystic" appearance on ultrasound).
  5. Without a dominant mature follicle, the LH surge does not occur normally, and ovulation is delayed or absent.
  6. Without ovulation, the corpus luteum does not form, and progesterone production is absent or low.
  7. Unopposed estrogen exposure thickens the endometrium without the protective effect of cyclic progesterone, contributing to heavy bleeding when periods do occur and to longer-term endometrial cancer risk.

Other phenotypes exist (adrenal PCOS, lean PCOS, post-pill PCOS), but the insulin-androgen loop is the most common pattern.

Cycle syncing with PCOS

The standard four-phase model assumes predictable ovulation. In PCOS, the follicular phase can stretch indefinitely without an LH surge, which means there is no reliable luteal phase, no PMS week, and no calendar-based phase prediction.

Two adaptations work:

1. Track ovulation directly, not by calendar.

Use ovulation predictor kits or basal body temperature to detect ovulation when it happens. When you confirm ovulation, start counting the luteal phase from that day. Some PCOS users ovulate but unpredictably (day 20, day 40, day 60); direct tracking catches it whenever it occurs.

2. Use the four work modes without strict calendar mapping.

If ovulation tracking is too high-effort or you do not ovulate consistently, the phase rotation of work modes (Reflect, Build, Connect, Finish) can still work as a 28-day structural rotation regardless of hormonal events. The biological rationale is weaker, but many users report the structure alone helps.

Treatment angles

PCOS management depends on goals (regular cycles, fertility, acne, metabolic health). Common interventions:

  • Lifestyle. Resistance training, walking, sleep, and a diet that supports insulin sensitivity. The evidence here is strongest for managing the metabolic side.
  • Inositol supplementation. Myo and D-chiro inositol show good evidence for improving ovulation rates and insulin sensitivity. Often the first-line supplement.
  • Metformin. Improves insulin sensitivity. Used both for metabolic management and to support ovulation.
  • Combined hormonal contraceptives. Suppress androgens by inducing predictable withdrawal bleeding and lowering free testosterone. Useful for acne and cycle regulation; does not address underlying insulin resistance.
  • Spironolactone. Anti-androgen used for acne and hirsutism.
  • Ovulation induction (letrozole, clomiphene). For users trying to conceive.
  • Spearmint tea. Small evidence for mild anti-androgenic effect; complementary, not primary.

All of these should be coordinated with a provider.

PCOS and the menstrual cycle

A few practical implications:

  • Periods may be infrequent, but when they occur they can be heavy due to longer estrogen exposure.
  • Anovulatory bleeding is common: bleeding without a true preceding ovulation.
  • Endometrial protection matters; persistent absence of cyclic progesterone is a long-term risk.
  • PMS does not happen in the standard sense (no progesterone withdrawal), but symptoms can occur from hormonal swings.

Related reading